CG
RXST icon

Caprock Group’s RxSight RXST Stock Holding History

Caprock Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Sell
18,803
-2,444
-12% -$20.3K ﹤0.01% 1074
2025
Q4 		$221K Buy
21,247
+2,286
+12% +$22.9K ﹤0.01% 1087
2025
Q3 		$171K Buy
+18,961
New +$166K ﹤0.01% 1077
2025
Q1 		$479K Hold
18,961
– – 0.01% 737
2024
Q4 		$652K Hold
18,961
– – 0.02% 539
2024
Q3 		$937K Sell
18,961
-32
-0.2% -$1.64K 0.03% 404
2024
Q2 		$1.14M Buy
+18,993
New +$1.09M 0.05% 334

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Caprock Group's RXST Position: Q1 2026 in Review

Caprock Group reduced its RxSight (RXST) stake by 12% in Q1 2026, selling an estimated $20.3K and leaving 18,803 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

Caprock Group first reported a position in RXST in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.14M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Caprock Group held 18,803 shares of RxSight worth $116K as of Q1 2026.
  • Caprock Group sold 2,444 RxSight shares in Q1 2026, an estimated $20.3K.
  • RxSight made up ﹤0.01% of Caprock Group's portfolio in Q1 2026, its #1074 holding.
  • Caprock Group first reported a position in RxSight in Q2 2024 and has held it in 7 quarters since.
  • Caprock Group's RxSight position peaked at $1.14M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.